MoneyWorks4Me

Hester Biosciences informs about earnings conference call

27 Jul 2020 Evaluate

Hester Biosciences  has informed that as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has arranged earnings conference call on Thursday, 30.07.2020 at 2:00 pm to discuss the Standalone and Consolidated Unaudited Financial Results for the quarter ended on 30.06.2020, as attached.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..